Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.74M 19.49M 17.82M 33.3M 2.26B 33.55M 234M 90.76M 1.15B 88.72M 86.77M 3.74B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 37.03M 34.8M 31.82M 59.46M 4.04B 59.9M 418M 162M 2.06B 158M 155M 6.68B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
04/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
15/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
Current month-15.38%
1 month+100.00%
3 months-46.34%
6 months-56.00%
Current year-33.33%
1 week 0
Extreme 0.0022
0
1 month 0
Extreme 0.0011
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-57.69%+100.00% 839K
-2.56%0.00%-33.33%-50.90% 1.75B
-3.19%+0.50% - - 1.59B
+0.05%-2.20%-29.59%+144.55% 1.13B
-1.05%-1.94%-45.54%+19.78% 1.08B
+0.29%-3.49%+203.17%+872.48% 1.03B
+0.30%-2.36%+41.23%+33.83% 945M
-0.21%+13.43%-5.97%+64.42% 812M
-0.54%-4.29%+11.17%+179.79% 764M
-7.03%+6.19%+47.92%-21.46% 555M
Average -1.39%-4.38%+14.60%+149.17% 965.36M
Weighted average by Cap. -1.51%+0.47%+17.12%+149.47%

Financials

2015 2016
Net sales 25.48M 22.36M 21.02M 19.22M 35.92M 2.44B 36.18M 253M 97.89M 1.24B 95.69M 93.59M 4.03B 32.33M 28.38M 26.67M 24.39M 45.57M 3.1B 45.91M 320M 124M 1.58B 121M 119M 5.12B
Net income 5.49M 4.82M 4.53M 4.14M 7.75M 526M 7.8M 54.45M 21.11M 268M 20.63M 20.18M 870M 2.06M 1.81M 1.7M 1.55M 2.91M 197M 2.93M 20.43M 7.92M 101M 7.74M 7.57M 326M
Net Debt 24.8M 21.77M 20.46M 18.71M 34.96M 2.38B 35.22M 246M 95.29M 1.21B 93.15M 91.11M 3.93B 18.56M 16.29M 15.31M 14M 26.16M 1.78B 26.36M 184M 71.3M 906M 69.7M 68.17M 2.94B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
22/09/26 $0.002200 0.00% 500
16/09/26 $0.002200 -48.84% 700
  1. Stock Market
  2. Stocks
  3. AOXG Stock